TIAPRIDAL

This brand name is authorized in France, Germany, Lithuania, Poland, Romania, Tunisia.

Active ingredients

The drug TIAPRIDAL contains one active pharmaceutical ingredient (API):

1	Tiapride UNII 25N106WEDO - TIAPRIDE HYDROCHLORIDE
	Tiapride is an atypical neuroleptic which exhibits selectivity in in-vitro studies for D2 and D3 dopamine subtype receptors without any affinity for subtype receptors of the principal central neurotransmitters (including serotonin, noradrenaline and histamine).
	Read more about Tiapride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AL03	Tiapride	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AL Benzamides
Discover more medicines within N05AL03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00356843, 00673124, 00673130
FR	Base de données publique des médicaments	67890598, 68632565, 68673220
LT	Valstybinė vaistų kontrolės tarnyba	1003179, 1003180, 1059789
PL	Rejestru Produktów Leczniczych	100098941, 100292844, 100316036, 100324998, 100335795, 100349685, 100353600, 100366235, 100384546, 100395047, 100410829, 100422063, 100422123, 100429289, 100468528
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63530001
TN	Direction de la Pharmacie et du Médicament	6483141, 6483142